U
GrantUnlock
Science & Technology

DoW Vision, Investigator-Initiated Research Award

Defense Health Agency Contracting Activity - DHACA

Opportunity #: HT942526VRPIIRA

Award Ceiling
N/A
Award Floor
N/A
Close Date
Nov 12, 2026
108 days left
Total Funding
$4.4M
Expected Awards
5
Posted Date
May 5, 2026
Cost Sharing Required
No
Grants.gov ID
362184

Description

Summary: The fiscal year 2026 (FY26) Vision Research Program (VRP) Investigator-Initiated Research Award (IIRA) supports basic through early translational research that will yield highly impactful discoveries or major advancements in the research and/or patient care of eye injury and/or visual dysfunction related to military exposure. The IIRA may be used to support preclinical studies and/or clinical research. Research must align with at least one of the FY26 VRP Focus Areas. The IIRA cannot be used to support clinical trials. Distinctive Features: The IIRA offers two Funding Levels to support research at different stages and the exploration/development of ideas of different maturity levels. Funding Level 2 includes a Partnering Principal Investigator (PI) Option (PPIO) for two PIs, an Initiating PI and a Partnering PI. Scored peer review criteria include Research Idea/Rationale, Research Strategy and Feasibility, Impact, and Personnel. Programmatic review criteria include adherence to the intent of the IIRA, contribution to the VRP portfolio, relative impact, and relevance to military health. The VRP may share FY26 IIRA applications and reviews with the National Eye Institute (NEI) for independent funding consideration. https://cdmrp.health.mil/pubs/press/2026/vrppreann

Apply on Grants.gov

Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.

View on Grants.gov
Disclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.